MHRA’s AI Airlock to address challenges for regulating AI medical devices
The sandbox will help to inform future AI Airlock projects and influence future AlaMD guidance The Medicines and…
Read MoreThe sandbox will help to inform future AI Airlock projects and influence future AlaMD guidance The Medicines and…
Read MoreFor the second month in a row, the NHS has met the 28-day faster diagnosis target for cancer…
Read MoreThe subtype accounts for 20% of all T-cell leukaemias, a rare form of blood cancer which produces too…
Read MoreAnticancer drugs will be responsible for 90% of nearly 612,000 predicted US cancer deaths in 2024 Oregon Therapeutics…
Read MoreGossamer’s seralutinib is designed to treat pulmonary arterial hypertension and other indications Chiesi Group and Gossamer Bio have…
Read MoreThe findings could potentially lead to new therapies and could stop the growth of cancers Johns Hopkins Medicine…
Read MoreThe rare and fatal progressive neurodegenerative disease is estimated to affect 5,000 people in the UK The Francis…
Read MoreThe chronic brain disease that causes seizures currently affects around 600,000 people living in the UK The NHS…
Read MoreThe INTerpath-001 trial is evaluating Moderna/Merck’s mRNA-4157 in combination with Merck’s Keytruda A phase 3 international trial evaluating…
Read MoreNeurological disorders, such as epilepsy or chronic pain, affect over three billion people worldwide Researchers at the University…
Read More